Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03911557 |
Title | Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | John L. Villano, MD, PhD |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Markey Cancer Center | Lexington | Kentucky | 40536 | United States | Details |